- Cumberland Pharma., Inc. v. Mylan Institutional LLC
- Mylan Laboratories Ltd., v. U.S. Food and Drug Administration
- December 21, 2012The Year The AIA's Post-Grant Processes Took Hold
- December 18, 2012The Art of Quantification
- December 5, 2012Attaching a Copy of Policy Upon Renewal: Insurers' Duty?
- December 3, 2012When Discovery Clashes with Privacy Law
- December 2012Understanding a Team Approach to Medical Malpractice Cases
- November 27, 2012Does Employer or Employee Own Social Media Assets?
- November 13, 2012Recognizing Bariatric Surgery Medical Malpractice
- Fall 2012ANDA Litigation Settlements
- Generic Launches Q3 2012
- Fall 2012ANDA Approvals
- Fall 2012New ANDA Cases
- Momenta Pharm., Inc. v. Amphastar Pharm., Inc.
- Astrazeneca AB v. Hanmi USA, Inc.
- Sciele Pharm. Inc. v. Lupin Ltd.
- Janssen Pharm., Inc. v. Watson Labs., Inc.
- Pfizer Inc. v. Teva Pharm. U.S.A., Inc.
- ISTA Pharm., Inc. v. Food and Drug Administration
- Novo Nordisk A/S v. Caraco Pharm. Labs., Ltd.
- In re K-Dur Antitrust Litigation
- Pozen Inc. v. Par Pharm., Inc.
- Santarus, Inc. v. Par Pharm., Inc.
- Alcon Research, Ltd. v. Apotex Inc.
- Galderma Labs., L.P., v. Tolmar, Inc.
- Eli Lilly & Co. v. Teva Parenteral Meds. Inc.
- Akamai Technologies, Inc. v. Limelight Networks, Inc.
- Senju Pharm. Co. v. Apotex, Inc.
- GlaxoSmithKline PLC v. Hikma Pharm. Co. Ltd.
- October 11, 2012The Role of Emails in Insurance Choice-Of-Law Analysis
- October 1, 2012The Art and Science of Case Selection
- October 1, 2012Courtroom developments and their impact on patent monetisation
- September 28, 2012Violence Against Women in the Dakotas
- September 15, 2012Funding Litigation - Chapter 10
- September 14, 2012The New Post-Issuance Procedures: The PTO's Final Rules on Discovery and Trial Practice
- September 1, 2012Defining Market Manipulation
- August 20, 2012Following The Money To Resolve Policy Disputes
- August 20, 2012From the Experts: Company vs. Employee Ownership of Social Media Assets
- Mylan Pharma. Inc. v. Sebelius
- Caraco Pharm. Labs., Ltd. v. Novo Nordisk A/S
- Otsuka Pharm. Co. v. Sandoz, Inc.
- Pronova Biopharma Norge AS v. Teva Pharma. USA Inc.
- Hospira, Inc. v. Sandoz Inc.
- Schering Corp. v. Apotex Inc.
- Teva Women’s Health, Inc. v. Lupin, Ltd.
- Allergan, Inc. v. Watson Laboratories, Inc.
- Warner Chilcott Labs Ireland Ltd. v. Mylan Pharma. Inc.
- Federal Trade Commission v. Watson Pharmaceuticals, Inc.
- Bone Care Int’l, LLC v. Roxane Laboratories, Inc.
- OSI Pharma., Inc. v. Mylan Pharma. Inc.
